Price
Target price
€7.00
€7.00
0.210%
0.015
0.210%
€13.37
30.07.25 / Stuttgart Stock Exchange
WKN: A3DWPS / Symbol: KALA / Name: Kala Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Kala Pharmaceuticals Inc. Stock
Kala Pharmaceuticals Inc. gained 0.210% compared to yesterday.
We see a rather positive sentiment for Kala Pharmaceuticals Inc. with 8 Buy predictions and 1 Sell predictions.
With a target price of 13 € there is a hugely positive potential of 85.71% for Kala Pharmaceuticals Inc. compared to the current price of 7.0 €.
So far the community has only identified positive things for Kala Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Kala Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kala Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | 0.210% | 48.620% | 82.959% | 21.003% | 8.696% | -56.400% | -98.108% |
| Krystal Biotech | 1.900% | 2.919% | 14.824% | -28.571% | -11.958% | 87.413% | - |
| Ardelyx Inc. | -0.870% | 2.121% | 14.166% | -25.441% | -23.384% | 460.153% | -30.202% |
| Evolus Inc | -1.270% | -3.125% | 0.649% | -30.180% | -26.190% | -32.609% | 164.505% |
Comments
KALA BIO, Inc. (NASDAQ: KALA) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $12.00 price target on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Show more
Ratings data for KALA provided by MarketBeat